Keywords: CDC; Centers for Disease Control and Prevention; CLABSI; central line-associated bloodstream infections; CRBSI; catheter-related bloodstream infection; CVAD; central venous access device; FDA; US Food and Drug Administration; HL7 FHIR; Health Level 7 Fa
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: blastic plasmacytoid dendritic cell neoplasm; hematopoietic stem cell transplantation; hyper-CVAD chemotherapy; localized skin-limited blastic plasmacytoid dendritic cell neoplasm; ALL; acute lymphoblastic leukemia; BPDCN; blastic plasmacytoid dendritic c
Keywords: CP; chest port; CVAD; central venous access device; CVS; central venous stent; IJ; internal jugular; SVC; superior vena cava;
Keywords: cost savings; CVAD; occlusion; spherical chamber; sludge; thrombosis; VAP; VAP-BSI
Primary Central Nervous System Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Colliding with Meningioma
Keywords: Collision tumor; Extranodal NK/T cell lymphoma; nasal type; Meningioma; CNS; Central nervous system lymphoma; CVAD; Cyclophosphamide, vincristine, Adriamycin (doxorubicin), dexamethasone; ENKTCL; Extranodal natural killer/T-cell lymphoma; MRI; Magnetic re
Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer
Keywords: Adjuvant chemotherapy; Colon cancer; CVAD; Peripheral venous access; XELOX;
Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE®), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: A multicentre, retrospective study
Keywords: AE; Adverse event; BU; Bethesda units; CR; Complete response; CVAD; Central venous access device; F; Failed ITI; FEIBA; FVIII inhibitor bypassing activity; FVIII; Factor VIII; HTC; Haemophilia treatment centre; I-ITI; International Immune Tolerance study;
Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
Keywords: CS; chondroitin 4-sulfate; CVAD; central venous access device; DS; dermatan sulfate; ECG; electrocardiogram; ERT; enzyme replacement therapy; GAG(s); glycosaminoglycan(s); HSCT; hematopoietic stem cell transplantation; LA; left atrial; LV; left ventricula
Epidemiology and Risk Factors for Thromboembolic Complications of Childhood Nephrotic Syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) Study
Keywords: APL; Antiphospholipid antibodies/lupus anticoagulant; AT3; Antithrombin III; CI; Confidence interval; CVAD; Central venous access device; DVT; Deep venous thrombosis; FVL; Factor V Leiden; MN; Membranous nephropathy; NS; Nephrotic syndrome; OR; Odds ratio
A new approach to improve SCC resistance of austenitic stainless steel with a thin CrN film, deposited by cathodic vacuum arc deposition technique
Keywords: CVAD; Chromium nitride; Corrosion; SCC;
Alteplase for the Treatment of Central Venous Catheter Occlusion in Children: Results of a Prospective, Open-label, Single-arm Study (The Cathflo Activase Pediatric Study)
Keywords: CAPS; Cathflo Activase Pediatric Study; COOL; Cardiovascular Thrombolytic to Open Occluded Lines [trial]; CVAD; central venous access device; FDA; Food and Drug Administration; ICH; intracranial hemorrhage;